Health
Researchers create AI system that matches tumors to best drug combinations – News-Medical.net
Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
Reviewed by Emily Henderson, B.Sc.Oct 23 2020
Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
That’s because right now we can’t match the right combination of drugs to the right patients in a smart way. And especially for cancer, where we can’t always predict which drugs will work best given the unique, complex inner workings of a person’s tumor cells.”
Trey Ideker, PhD, Professor, School of Medicine and Moores…
-
Noosa News23 hours agoCCTV footage shows stolen ute slamming into fuel bowsers at Kojonup petrol station
-
Noosa News24 hours agoPappa Flock is Now Open in Westfield Chermside
-
Noosa News20 hours agoDid you lose your ring?
-
Business23 hours agoWill GQG Partners shares rise from here? Macquarie reveals its forecast post-results